Showing results (111-120 of 161) with videos related to

Sort By:
Pageof 17
Targeted Oncology|October 14, 2022
Real-World Activity and Safety of Trifluridine-Tipiracil Plus Bevacizumab Therapy in Patients with Refractory Metastatic Colorectal CancerGianluca Arrichiello, Alessandra Perrone, Stefania Napolitano, et al.
ESMO Open|December 2, 2020
Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology AssociationLisa Salvatore, Marco Imperatori, Ermenegildo Arnoldi, et al.
Medicine|May 25, 2019
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variantVincenzo De Falco, Maria Iole Natalicchio, Stefania Napolitano, et al.
BMC Cancer|November 12, 2025
Agnostic phase II, multicenter, single-arm study with DURVAlumab plus carboplatin or cisplatin and etoposide as first-line treatment in extensive stage - Extrapulmonary Small Cell Carcinoma (EPSCC) patients - DURVASCC trial (GOIRC-01-2021)Angela Damato, Giuseppe Maglietta, Lorenzo Antonuzzo, et al.
International Journal of Cancer|May 1, 2013
Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cellsErika Martinelli, Teresa Troiani, Elena D'Aiuto, et al.
Analytical and Bioanalytical Chemistry|July 12, 2024
Development of a supramolecular solvent-based extraction method for application to quantitative analyses of a wide range of organic contaminants in indoor dustPaula Marcinekova, Lisa Melymuk, Pernilla Bohlin-Nizzetto, et al.
Frontiers in Oncology|August 5, 2022
Beyond N staging in colorectal cancer: Current approaches and future perspectivesGianluca Arrichiello, Mario Pirozzi, Bianca Arianna Facchini, et al.
Oncotarget|May 13, 2015
AXL is an oncotarget in human colorectal cancerErika Martinelli, Giulia Martini, Claudia Cardone, et al.
International Journal of Cancer|April 16, 2022
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumabGiulia Martini, Davide Ciardiello, Marcello Dallio, et al.
Clinical Drug Investigation|June 17, 2024
Radiomic Parameters for the Evaluation of Response to Treatment in Metastatic Colorectal Cancer Patients with Liver Metastasis: Findings from the CAVE-GOIM mCRC Phase 2 TrialErika Martinelli, Davide Ciardiello, Giulia Martini, et al.
Pageof 17